You are here: Home » News-CM » Companies » News
Business Standard

Dr Reddy's Laboratories update on patent litigation for Buprenorphine and Naloxone Sublingual Film

Capital Market 

Dr Reddy's Laboratories has provided update on patent litigation with respect to generic Buprenorphine and Naloxone Sublingual Film in the U.

S. Market.

The Judge has heard the matter on 28 June 2018 and extended the temporary restraining order for a further period of 14 days pending his decision.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, June 29 2018. 10:47 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU